{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:16:20Z","timestamp":1748405780416,"version":"3.41.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Models estimating risk for advanced proximal colorectal neoplasia (APN) may be used to select colorectal cancer (CRC) screening test, either prior to knowing distal colorectal findings or afterward. Current models have only fair discrimination and nearly all require knowing distal findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Derive and test risk prediction models for APN with and without distal findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting<\/jats:title>\n            <jats:p>Selected endoscopy centers within central Indiana, USA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Participants<\/jats:title>\n            <jats:p>Average-risk persons undergoing first-time screening colonoscopy<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions<\/jats:title>\n            <jats:p>Demographics, personal and family medical history, lifestyle factors and physical measures were linked to the most advanced finding in proximal and distal colorectal segments. For both models, logistic regression identified factors independently associated with APN on a derivation set. Based on equation coefficients, points were assigned to each factor, and risk for APN was examined for each score. Scores with comparable risks were collapsed into risk categories. Both models and their scoring systems were tested on the validation set.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main outcome<\/jats:title>\n            <jats:p>APN, defined as any adenoma or sessile serrated lesion \u22651 cm, one with villous histology or high-grade dysplasia, or CRC proximal to the descending colon.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 3025 subjects in the derivation set (mean age 57.3 \u00b1 6.5 years; 52% women), APN prevalence was 4.5%; 2859 (94.5%) had complete data on risk factors. Independently associated with APN were age, sex, cigarette smoking, cohabitation status, metabolic syndrome, non-steroidal anti-inflammatory drug use and physical activity. This model (without distal findings) was well-calibrated (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.62) and had good discrimination (c-statistic = 0.73). In low-, intermediate- and high-risk groups that comprised 21, 58 and 21% of the sample, respectively, APN risks were 1.47% (95% CI, 0.67\u20132.77%), 3.09% (CI, 2.31\u20134.04%) and 11.6% (CI, 9.10\u201314.4%), respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001), with no proximal CRCs in the low-risk group and 2 in the intermediate-risk group. When tested in the validation set of 1455, the model retained good metrics (calibration <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.85; c-statistic = 0.83), with APN risks in low- (22%), intermediate- (56%) and high-risk (22%) subgroups of 0.62% (CI, 0.08\u20132.23%) 2.20% (CI, 1.31\u20133.46%) and 13.0% (CI, 9.50\u201317.2%), respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). There were no proximal CRCs in the low-risk group, and two in the intermediate-risk group. The model with distal findings performed comparably, with validation set metrics of 0.18 for calibration, 0.76 for discrimination and APN risk (% sample) in low-, intermediate-, and high-risk groups of 1.1 (69%), 8.3 (22%) and 22.3% (9%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These models stratify large proportions of average-risk persons into clinically meaningful risk groups, and could improve screening efficiency, particularly for noncolonoscopy-based programs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000715","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T08:01:48Z","timestamp":1632211308000},"page":"318-325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["New scoring systems for predicting advanced proximal neoplasia in asymptomatic adults with or without knowing distal colorectal findings: a prospective, cross-sectional study"],"prefix":"10.1097","volume":"31","author":[{"given":"Thomas F.","family":"Imperiale","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine"},{"name":"The Center for Innovation, Health Services Research and Development, Roudebush Virginia Medical Center"},{"name":"Regenstrief Institute; Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick O.","family":"Monahan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E.","family":"Stump","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Ransohoff","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3748\/wjg.v24.i1.124","article-title":"Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations.","volume":"24","author":"B\u00e9nard","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0016-5107(04)00155-5","article-title":"Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy.","volume":"59","author":"Bet\u00e9s Ib\u00e1\u00f1ez","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2307\/2531779","article-title":"Best subsets logistic regression.","author":"Hosmer","year":"1989","journal-title":"Biometrics"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/M14-1720","article-title":"Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study.","volume":"163","author":"Imperiale","year":"2015","journal-title":"Ann Intern Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-139-12-200312160-00005","article-title":"Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.","volume":"139","author":"Imperiale","year":"2003","journal-title":"Ann Intern Med"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"djw181","DOI":"10.1093\/jnci\/djw181","article-title":"Risk of advanced neoplasia using the National Cancer Institute\u2019s colorectal cancer risk assessment tool.","volume":"109","author":"Imperiale","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1155\/2010\/683171","article-title":"Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010.","volume":"24","author":"Leddin","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ajg.2011.20","article-title":"Performance of a risk index for advanced proximal colorectal neoplasia among a racially\/ethnically diverse patient population (risk index for advanced proximal neoplasia).","volume":"106","author":"Levitzky","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.2016.3332","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force.","volume":"315","author":"Lin","year":"2016","journal-title":"JAMA"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"46493","DOI":"10.1038\/srep46493","article-title":"An algorithm to predict advanced proximal colorectal neoplasia in Chinese asymptomatic population.","volume":"7","author":"Liwen Huang","year":"2017","journal-title":"Sci Rep"},{"key":"R13-20250527","first-page":"661","article-title":"Some comments on C p.","volume":"15","author":"Mallows","year":"1973","journal-title":"Technometrics"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0b013e3181b5369b","article-title":"Colonoscopy performance in a large private practice: a comparison to quality benchmarks.","volume":"44","author":"Morelli","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.gie.2012.06.013","article-title":"Risk stratification for advanced proximal colon neoplasm and individualized endoscopic screening for colorectal cancer by a risk-scoring model.","volume":"76","author":"Park","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41395-018-0209-2","article-title":"Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis.","volume":"113","author":"Peng","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.gie.2014.02.001","article-title":"Advanced proximal neoplasia of the colon in average-risk adults.","volume":"80","author":"Rabeneck","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.gie.2014.12.028","article-title":"Evaluation of a risk index for advanced proximal neoplasia of the colon.","volume":"81","author":"Ruco","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/gut.2007.146316","article-title":"Asia Pacific consensus recommendations for colorectal cancer screening.","volume":"57","author":"Sung","year":"2008","journal-title":"Gut"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2014.10.003","article-title":"Identification of subjects at risk of proximal advanced neoplasia for colorectal cancer screening.","volume":"51","author":"Wong","year":"2015","journal-title":"Eur J Cancer"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/gutjnl-2013-305639","article-title":"A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.","volume":"63","author":"Wong","year":"2014","journal-title":"Gut"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:04:28Z","timestamp":1748361868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000715","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2021,9,17]]}}}